Analyst Reco. bioMérieux

Stocks

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris Other stock markets 05:22:21 2026-06-10 am EDT			5-day change	1st Jan Change
70.70 ^EUR	-0.84%		-0.14%	-35.90%

Jun. 09	What Bundibugyo Ebola vaccines and treatments are under development	RE
Jun. 04	What Bundibugyo Ebola vaccines and treatments are under development	RE

Analyst Reco.

Jun. 01	BioMérieux in the red following UBS downgrade
Jun. 01	UBS Downgrades bioMérieux to Neutral, Cuts PT	MT
Jun. 01	UBS downgrades bioMérieux to neutral, shares retreat
Jun. 01	French Analyst Ratings: UBS downgrades Biomerieux, Soitec remains in favor
Apr. 24	Deutsche Bank Downgrades bioMérieux to Hold, Cuts PT	MT
Apr. 23	BioMerieux: Disappointing Q1 and lower guidance undermine investor confidence
Apr. 13	RBC Capital Favors Diasorin Over bioMérieux
Apr. 10	AlphaValue Urges Patience on bioMérieux, Maintains Buy Rating
Mar. 05	TP ICAP Midcap Downgrades BioMérieux to Hold, Cuts PT	MT
Mar. 02	BioMérieux Still Has Upside Potential, Says All Invest Securities
Feb. 27	BioMerieux: 2025 promise delivered; 2026 targets in sight
Feb. 02	Oddo BHF Voices Concerns Over Currency Impact and Weaker Flu Season for bioMérieux
Jan. 20	TP ICAP Midcap Upgrades bioMérieux to Buy	MT
Nov. 10	UBS Maintains Buy Rating on BioMérieux, Confirms Price Target
Nov. 05	Analysts Maintain Buy Ratings on bioMérieux After Q3 Results
Nov. 05	Invest Securities Upgrades bioMérieux to Buy	MT
Nov. 05	BioMérieux: Invest Securities upgrades stock after quarterly results
Nov. 04	Biomérieux Q3 earnings miss prompts softer 2025 guidance
Nov. 04	Stifel remains bullish on BioMérieux after trading update.
25-10-22	CIC Market Solutions Upgrades bioMérieux to Buy, Boosts PT	MT
25-09-11	BioMérieux: UBS Raises Price Target
25-09-11	BioMérieux: UBS raises target price
25-09-05	BioMérieux: Invest Securities Downgrades Rating to Neutral
25-09-05	BioMérieux: Invest Securities downgrades stock
25-09-05	Invest Securities Downgrades bioMérieux to Neutral, Lowers PT	MT